- Home
- JZXN vs PEPG Comparison
JZXN vs PEPG Comparison
Compare JZXN & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- PEPG
- Stock Information
- Founded
- JZXN 2019
- PEPG 2018
- Country
- JZXN China
- PEPG United States
- Employees
- JZXN N/A
- PEPG N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- JZXN Consumer Discretionary
- PEPG Health Care
- Exchange
- JZXN Nasdaq
- PEPG Nasdaq
- Market Cap
- JZXN 51.8M
- PEPG 45.9M
- IPO Year
- JZXN 2021
- PEPG 2022
- Fundamental
- Price
- JZXN $0.81
- PEPG $1.49
- Analyst Decision
- JZXN
- PEPG Buy
- Analyst Count
- JZXN 0
- PEPG 3
- Target Price
- JZXN N/A
- PEPG $7.67
- AVG Volume (30 Days)
- JZXN 239.1K
- PEPG 335.1K
- Earning Date
- JZXN 03-05-2026
- PEPG 11-06-2025
- Dividend Yield
- JZXN N/A
- PEPG N/A
- EPS Growth
- JZXN N/A
- PEPG N/A
- EPS
- JZXN N/A
- PEPG N/A
- Revenue
- JZXN $97,465.00
- PEPG N/A
- Revenue This Year
- JZXN N/A
- PEPG N/A
- Revenue Next Year
- JZXN N/A
- PEPG N/A
- P/E Ratio
- JZXN N/A
- PEPG N/A
- Revenue Growth
- JZXN N/A
- PEPG N/A
- 52 Week Low
- JZXN $0.78
- PEPG $0.88
- 52 Week High
- JZXN $7.82
- PEPG $10.06
- Technical
- Relative Strength Index (RSI)
- JZXN 37.98
- PEPG 64.86
- Support Level
- JZXN $0.78
- PEPG $1.13
- Resistance Level
- JZXN $0.85
- PEPG $1.32
- Average True Range (ATR)
- JZXN 0.05
- PEPG 0.09
- MACD
- JZXN 0.01
- PEPG 0.03
- Stochastic Oscillator
- JZXN 20.00
- PEPG 87.80
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.